IPO Boutique

MyoKardia, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on MyoKardia, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
MyoKardia, Inc.MYOK -
NASDAQ
$15.00-$17.00 $10.00 $11.085.4 million10/29/2015
Credit Suisse, Cowen & Co.
Co-Manager(s):
Wells Fargo Securities, Wedbush PacGrow
Health Care
Filing(s):

Filed 2015-09-28
Underwriters Changed 2015-10-13
Terms Added 2015-10-19



MyoKardia, Inc. Quote & Chart - Click for current quote - MYOK

About MyoKardia, Inc. (adapted from MyoKardia, Inc. prospectus):
They are a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MYOK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved